Article Details
Retrieved on: 2024-06-22 20:34:08
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Neurona Therapeutics' NRTX-1001, an investigational allogeneic regenerative neural cell therapy intended to treat drug-resistant mesial temporal lobe ...
Article found on: www.cgtlive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here